478 related articles for article (PubMed ID: 18977174)
1. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease.
Rizvi M; Pathak D; Freedman JE; Chakrabarti S
Trends Mol Med; 2008 Dec; 14(12):530-8. PubMed ID: 18977174
[TBL] [Abstract][Full Text] [Related]
2. The CD40/CD40L system: a new therapeutic target for disease.
Zhang B; Wu T; Chen M; Zhou Y; Yi D; Guo R
Immunol Lett; 2013 Jun; 153(1-2):58-61. PubMed ID: 23892087
[TBL] [Abstract][Full Text] [Related]
3. The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
Antoniades C; Bakogiannis C; Tousoulis D; Antonopoulos AS; Stefanadis C
J Am Coll Cardiol; 2009 Aug; 54(8):669-77. PubMed ID: 19679244
[TBL] [Abstract][Full Text] [Related]
4. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.
Zirlik A; Maier C; Gerdes N; MacFarlane L; Soosairajah J; Bavendiek U; Ahrens I; Ernst S; Bassler N; Missiou A; Patko Z; Aikawa M; Schönbeck U; Bode C; Libby P; Peter K
Circulation; 2007 Mar; 115(12):1571-80. PubMed ID: 17372166
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand: a neo-inflammatory molecule in vascular diseases.
Hassan GS; Merhi Y; Mourad W
Immunobiology; 2012 May; 217(5):521-32. PubMed ID: 21529993
[TBL] [Abstract][Full Text] [Related]
7. CD40/CD40L signaling and its implication in health and disease.
Chatzigeorgiou A; Lyberi M; Chatzilymperis G; Nezos A; Kamper E
Biofactors; 2009; 35(6):474-83. PubMed ID: 19904719
[TBL] [Abstract][Full Text] [Related]
8. CD40 and vascular inflammation.
Urbich C; Dimmeler S
Can J Cardiol; 2004 May; 20(7):681-3. PubMed ID: 15197419
[TBL] [Abstract][Full Text] [Related]
9. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
[TBL] [Abstract][Full Text] [Related]
10. CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism.
Ke ZJ; Calingasan NY; DeGiorgio LA; Volpe BT; Gibson GE
Neurochem Int; 2005 Aug; 47(3):204-15. PubMed ID: 15885854
[TBL] [Abstract][Full Text] [Related]
11. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
[TBL] [Abstract][Full Text] [Related]
12. CD40 and its ligand in atherosclerosis.
Lutgens E; Lievens D; Beckers L; Donners M; Daemen M
Trends Cardiovasc Med; 2007 May; 17(4):118-23. PubMed ID: 17482093
[TBL] [Abstract][Full Text] [Related]
13. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.
Chen K; Huang J; Gong W; Zhang L; Yu P; Wang JM
Cell Mol Immunol; 2006 Jun; 3(3):163-9. PubMed ID: 16893496
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine modulates the CD40/CD40L system.
Prontera C; Martelli N; Evangelista V; D'Urbano E; Manarini S; Recchiuti A; Dragani A; Passeri C; Davì G; Romano M
J Am Coll Cardiol; 2007 Jun; 49(22):2182-90. PubMed ID: 17543638
[TBL] [Abstract][Full Text] [Related]
15. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
[TBL] [Abstract][Full Text] [Related]
16. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
Engel D; Seijkens T; Poggi M; Sanati M; Thevissen L; Beckers L; Wijnands E; Lievens D; Lutgens E
Semin Immunol; 2009 Oct; 21(5):308-12. PubMed ID: 19616449
[TBL] [Abstract][Full Text] [Related]
17. Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease.
Danese S; Scaldaferri F; Vetrano S; Stefanelli T; Graziani C; Repici A; Ricci R; Straface G; Sgambato A; Malesci A; Fiocchi C; Rutella S
Gut; 2007 Sep; 56(9):1248-56. PubMed ID: 17317789
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II modulates CD40 expression in vascular smooth muscle cells.
Souza HP; Frediani D; Cobra AL; Moretti AI; Jurado MC; Fernandes TR; Cardounel AJ; Zweier JL; Tostes RC
Clin Sci (Lond); 2009 Mar; 116(5):423-31. PubMed ID: 18785879
[TBL] [Abstract][Full Text] [Related]
19. CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction.
Hausding M; Jurk K; Daub S; Kröller-Schön S; Stein J; Schwenk M; Oelze M; Mikhed Y; Kerahrodi JG; Kossmann S; Jansen T; Schulz E; Wenzel P; Reske-Kunz AB; Becker C; Münzel T; Grabbe S; Daiber A
Basic Res Cardiol; 2013 Nov; 108(6):386. PubMed ID: 24061433
[TBL] [Abstract][Full Text] [Related]
20. Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells.
Chougnet C
J Leukoc Biol; 2003 Nov; 74(5):702-9. PubMed ID: 12960257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
